Measles Antibody: Reevaluation of Protective Titers

R. T. Chen(Center for Biologics Evaluation and Research), W. A. Orenstein(Center for Biologics Evaluation and Research), Paul Albrecht(Center for Biologics Evaluation and Research), J. A. Stewart(Center for Biologics Evaluation and Research), S. R. Preblud(Center for Biologics Evaluation and Research), Lynne Mofenson(National Institutes of Health), Lauri E. Markowitz(Centers for Disease Control and Prevention)
The Journal of Infectious Diseases
November 1, 1990
10.1093/infdis/162.5.1036
Cited by 611

Related Papers

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
|PsycEXTRA Dataset|2007|1.9k
Prevalence of HPV Infection Among Females in the United States
|JAMA|2007|1.6k
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
|The Lancet|2019|1.3k
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.
|PubMed|2015|1.1k
Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States
|JAMA|2006|1k